X-14850676-TAAA-TAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001018113.3(FANCB):​c.1327-3delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0124 in 1,048,224 control chromosomes in the GnomAD database, including 294 homozygotes. There are 3,223 hemizygotes in GnomAD. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 143 hom., 929 hem., cov: 21)
Exomes 𝑓: 0.0098 ( 151 hom. 2294 hem. )

Consequence

FANCB
NM_001018113.3 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.476

Publications

2 publications found
Variant links:
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
FANCB Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • VACTERL association, X-linked, with or without hydrocephalus
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • VACTERL with hydrocephalus
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-14850676-TA-T is Benign according to our data. Variant chrX-14850676-TA-T is described in ClinVar as Benign. ClinVar VariationId is 93468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCBNM_001018113.3 linkc.1327-3delT splice_region_variant, intron_variant Intron 6 of 9 ENST00000650831.1 NP_001018123.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCBENST00000650831.1 linkc.1327-3delT splice_region_variant, intron_variant Intron 6 of 9 NM_001018113.3 ENSP00000498215.1

Frequencies

GnomAD3 genomes
AF:
0.0356
AC:
3757
AN:
105487
Hom.:
143
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0170
Gnomad ASJ
AF:
0.00156
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00972
Gnomad FIN
AF:
0.0130
Gnomad MID
AF:
0.0176
Gnomad NFE
AF:
0.00624
Gnomad OTH
AF:
0.0229
GnomAD2 exomes
AF:
0.0184
AC:
2302
AN:
125253
AF XY:
0.0132
show subpopulations
Gnomad AFR exome
AF:
0.121
Gnomad AMR exome
AF:
0.0121
Gnomad ASJ exome
AF:
0.00169
Gnomad EAS exome
AF:
0.00716
Gnomad FIN exome
AF:
0.0194
Gnomad NFE exome
AF:
0.00740
Gnomad OTH exome
AF:
0.0143
GnomAD4 exome
AF:
0.00976
AC:
9204
AN:
942709
Hom.:
151
Cov.:
19
AF XY:
0.00860
AC XY:
2294
AN XY:
266641
show subpopulations
African (AFR)
AF:
0.114
AC:
2595
AN:
22853
American (AMR)
AF:
0.0105
AC:
313
AN:
29747
Ashkenazi Jewish (ASJ)
AF:
0.00140
AC:
24
AN:
17082
East Asian (EAS)
AF:
0.00152
AC:
39
AN:
25600
South Asian (SAS)
AF:
0.00921
AC:
412
AN:
44744
European-Finnish (FIN)
AF:
0.0160
AC:
601
AN:
37467
Middle Eastern (MID)
AF:
0.0166
AC:
59
AN:
3547
European-Non Finnish (NFE)
AF:
0.00637
AC:
4596
AN:
721609
Other (OTH)
AF:
0.0141
AC:
565
AN:
40060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
294
588
881
1175
1469
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0357
AC:
3768
AN:
105515
Hom.:
143
Cov.:
21
AF XY:
0.0313
AC XY:
929
AN XY:
29659
show subpopulations
African (AFR)
AF:
0.109
AC:
3147
AN:
28862
American (AMR)
AF:
0.0170
AC:
165
AN:
9712
Ashkenazi Jewish (ASJ)
AF:
0.00156
AC:
4
AN:
2570
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3355
South Asian (SAS)
AF:
0.00980
AC:
24
AN:
2450
European-Finnish (FIN)
AF:
0.0130
AC:
65
AN:
5001
Middle Eastern (MID)
AF:
0.0146
AC:
3
AN:
206
European-Non Finnish (NFE)
AF:
0.00626
AC:
321
AN:
51278
Other (OTH)
AF:
0.0276
AC:
39
AN:
1412
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
122
244
366
488
610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00721
Hom.:
27
Bravo
AF:
0.0388
Asia WGS
AF:
0.0180
AC:
44
AN:
2514

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2019
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

not specified Benign:1
Apr 02, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

VACTERL with hydrocephalus Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Nov 24, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Fanconi anemia complementation group B Benign:1
Sep 24, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FANCB-related disorder Benign:1
Jul 01, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Mar 08, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi Anemia, X-Linked Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.48
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202067682; hg19: chrX-14868798; COSMIC: COSV60759099; API